Glucotrack (GCTK) EBITDA Margin (2014 - 2020)
Glucotrack (GCTK) posted EBITDA Margin of 629896.91% for Q2 2020, down 1711.37% on a QoQ basis from 34774.61% in Q1 2020, and down 62908771.0% year-over-year from N/an in Q3 2019.
Glucotrack (GCTK) EBITDA Margin (2014 - 2020) Analysis & Trends
Glucotrack's EBITDA Margin history runs 7 years deep, the most recent figure standing at 629896.91% for Q2 2020.
- Quarterly EBITDA Margin fell 62908771.0% year-over-year to 629896.91% in Q2 2020, while the trailing twelve-month figure through Sep 2020 was 5929.83% (up 725681.0% YoY) and the FY2019 annual result came in at 1685.58%, up 1672099.0% from the prior year.
- EBITDA Margin was 629896.91% for Q2 2020 at Glucotrack, down from 34774.61% in the prior quarter.
- Across five years, EBITDA Margin topped out at 9455.8% in Q4 2019 and bottomed at 629896.91% in Q2 2020.
- A 5-year average of 45883.65% and a median of 1219.42% in 2016 frame the typical range for EBITDA Margin.
- Annual changes were most pronounced in 2018 — EBITDA Margin surged 1715389 bps — and 2020, when it slumped 62908771 bps.
- Glucotrack's EBITDA Margin stood at 1020.51% in 2016, then surged by 490 bps to 3984.61% in 2017, then tumbled by 430 bps to 13130.81% in 2018, then surged by 172 bps to 9455.8% in 2019, then sank by 6761 bps to 629896.91% in 2020.
- Business Quant data shows GCTK's EBITDA Margin at 629896.91% in Q2 2020, 34774.61% in Q1 2020, and 9455.8% in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 98.77% |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 33.60% |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 1.97% |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 5.74% |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 34.92% |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 20.53% |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -2.87% |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 4.04% |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 13.65% |
| 10 | Glucotrack | 33.48 | -7.38 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | -629,896.91% |
| Mar 31, 2020 | -34,774.61% |
| Dec 31, 2019 | 9,455.80% |
| Sep 30, 2019 | -23,484.38% |
| Jun 30, 2019 | -809.19% |
| Mar 31, 2019 | 4,010.07% |
| Jun 30, 2018 | -13,130.81% |
| Mar 31, 2018 | 6,770.21% |
| Dec 31, 2017 | 3,984.61% |
| Sep 30, 2017 | -12,671.59% |
| Jun 30, 2017 | -30,284.70% |
| Mar 31, 2017 | 2,701.25% |
| Dec 31, 2016 | -1,020.51% |
| Sep 30, 2016 | -13,154.55% |
| Jun 30, 2016 | -414.80% |
| Mar 31, 2016 | -1,418.33% |
| Jun 30, 2015 | -1,627.81% |
| Mar 31, 2015 | -1,161.49% |
| Dec 31, 2014 | -3,102.19% |
| Sep 30, 2014 | -3,041.82% |